Table V.

Analytes with significantly different levels in clinically infected and non-infected patients

I-TAC, interferon γ-inducible T cell α chemoattractant; OSM, oncostatin M; PAI-II, plasminogen activator inhibitor-II, NGF, nerve growth factor.

Analyte	Clinically infected			Non-infected			Effect size	p value
	Mean	S.D.	n	Mean	S.D.	n
E-selectin	10.66	1.57	42	9.26	1.54	51	0.90	0.00004
IL-18	8.38	1.55	47	7.24	0.99	51	0.88	0.00004
IL-2sRα	8.91	0.99	38	8.08	0.99	52	0.84	0.0002
CRP	12.88	0.83	47	12.09	1.15	51	0.77	0.0002
uPAR	9.54	0.88	45	8.95	0.61	39	0.77	0.0007
uPA	7.82	0.40	45	7.53	0.47	39	0.67	0.003
P-selectin	11.65	1.19	41	10.80	1.33	51	0.66	0.002
NE	13.04	0.98	47	12.37	1.25	49	0.60	0.004
CA125	6.82	0.76	45	6.45	0.40	40	0.59	0.008
ICAM-1	12.30	0.87	43	11.83	0.79	37	0.57	0.01
OSM	6.75	0.49	47	6.48	0.47	54	0.57	0.005
PAI-II	6.01	0.89	47	5.55	0.74	50	0.57	0.006
CCL21	8.83	0.71	44	8.43	0.71	40	0.56	0.01
ET-3	5.81	0.57	45	5.52	0.49	41	0.55	0.01
ErbB2	9.07	0.37	43	8.87	0.39	40	0.55	0.01
FGFR3 (IIIb)	6.12	0.25	45	5.97	0.32	41	0.55	0.01
IL-16	7.11	0.75	43	6.73	0.63	37	0.54	0.02
MIP-3α	8.22	1.42	41	7.58	0.99	38	0.51	0.03
ErbB1	9.98	0.32	44	9.79	0.41	40	0.50	0.02
Eot-2	9.48	1.27	36	8.90	1.09	44	0.49	0.03
NGF-β	8.49	0.75	43	8.12	0.83	36	0.48	0.04
IL-1ra	7.31	1.64	45	6.68	1.00	52	0.47	0.02
I-TAC	6.95	1.01	43	6.58	0.53	38	0.46	0.04
MMP-8	12.33	1.88	41	11.41	2.06	50	0.46	0.03
MIP-1β	8.90	2.17	39	8.14	1.12	46	0.45	0.04
CD40	5.12	0.44	48	4.92	0.46	51	0.44	0.03
MPIF-1	6.42	0.77	49	6.13	0.58	55	0.44	0.03
MCP-2	5.97	0.78	48	5.70	0.51	54	0.42	0.04
IL-12p40	5.68	0.59	46	5.47	0.47	51	0.40	0.05
MMP-2	13.55	0.32	44	13.70	0.30	41	−0.48	0.03